CureVac Announces Proposed U.S. IPO of Common Shares to Raise $245M

Coinspeaker CureVac Announces Proposed U. S. IPO of Common Shares to Raise $245MCureVac B. V. , a Dutch biopharmaceutical company, filed for an initial public offering on Friday, with plans to list on Nasdaq under the ticker "CVAC. дальше »